ERBB3 and neoplasm: Based on the finding that pertuzumab increases HER3 expression, we compared the effect of the anti-HER3 mAb 9F7-F11 and of pertuzumab, which targets HER3 indirectly (Figure 4D), on BxPC-3 tumor xenograft growth.